Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Pilot Efficacy of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection

NCT02364583 is registered in ClinicalTrials.gov with Papua New Guinea Institute of Medical Research as lead sponsor.

NCT NCT02364583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02364583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Pilot Efficacy of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Lead sponsor
Papua New Guinea Institute of Medical Research
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2010
Completion date
December 31, 2016
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium vivax